SCHEMBL28686154

SCHEMBL28686154

Ic1n[nH]c2ccc(Cc3ccccc3)cc12

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NTRK1 P04629 7/20 0.45
▸ GSK3B P49841 3/20 0.43
▸ ITK Q08881 1/20 0.42
▸ CDC7 O00311 3/20 0.41
▸ JAK2 O60674 3/20 0.41
▸ ROCK2 O75116 2/20 0.41
▸ MAP4K4 O95819 2/20 0.41
▸ PAK4 O96013 2/20 0.41
▸ PIM1 P11309 2/20 0.41
▸ PRKACA P17612 2/20 0.41
▸ CDK2 P24941 2/20 0.41
▸ KDR P35968 2/20 0.41
▸ AURKB Q96GD4 2/20 0.41
▸ HIPK2 Q9H2X6 2/20 0.41
▸ CLK4 Q9HAZ1 2/20 0.41
▸ MKNK2 Q9HBH9 2/20 0.41
▸ IRAK4 Q9NWZ3 2/20 0.41
▸ IDH1 O75874 1/20 0.40
▸ PLK4 O00444 1/20 0.39
▸ AURKA O14965 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3512392 0.82 JAK2 (0.58) NTRK1GSK3BCDC7JAK2ROCK2
SCHEMBL13375276 0.78 MAP2K4 (0.49) NTRK1JAK2PDPK1FGFR1MAPKAPK2
SCHEMBL17871939 0.76 KDM4E (0.58) NTRK1HAO1GABRA1GABRB2
SCHEMBL2574384 0.76 TTK (0.55) NTRK1
SCHEMBL2570073 0.76 NTRK1 (0.42) NTRK1JAK2ROCK2KDRMKNK2
SCHEMBL2557897 0.74 TTK (0.60) ITKJAK2KDRAKT1MAPK8
SCHEMBL16025864 0.74 NTRK1 (0.59) NTRK1ITKCDC7MAP4K4CDK2
SCHEMBL29693067 0.73 MEN1 (0.53) IDH1CALM1GABRA1GABRB2
SCHEMBL6583054 0.72 PARP1 (0.49) NTRK1GSK3BITKCDC7JAK2
SCHEMBL6586654 0.72 PARP1 (0.46) NTRK1GSK3BITKCDC7JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114072387-B Indazole compound, pharmaceutical composition and application thereof 暨南大学 2024-03-08 — — CN disclosed
EP-4056558-A1 INDAZOLE COMPOUND, PHARMACEUTICAL COMPOSITION OF SAME, AND APPLICATIONS THEREOF Jinan University (CN) 2022-09-14 — — EP disclosed
US-20220281821-A1 INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS JINAN UNIVERSITY (CN) 2022-09-08 — — US disclosed
CN-114072387-A Indazole compound and medicinal composition and application thereof 暨南大学 2022-02-18 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220281821-A1 INDAZOLE COMPOUNDS AND THEIR PHARMACEUTICAL COMPOSITIONS TNK2, TNNI3K, CSNK1G3 NTRK1 63/4885GSK3B 34/4885ITK 223/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback